ArticleFrontiers in immunology2021

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma.

Dongjie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.